Related Experiment Videos
[Predictive value of cardiovascular events by high sensitivity CRP]
Haruo Nakamura1, Takeshi Yamashita
1Mitsukoshi Health & Welfare Foundation.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 28, 2002
Summary
C-reactive protein (CRP) is a cardiovascular risk marker. In Japanese individuals, the upper reference limit is 2.0 mg/l, and elevated CRP indicates poor prognosis, but statin therapy can help prevent cardiovascular events.
Area of Science:
- Biochemistry
- Cardiology
- Clinical Chemistry
Context:
- C-reactive protein (CRP) is increasingly recognized as a significant biomarker for cardiovascular risk.
- Clarification is needed regarding reference values and predictive capabilities in specific populations, such as hypercholesterolemic Japanese subjects.
- Body fat percentage influences CRP levels, suggesting a link between metabolic health and inflammation.
Purpose:
- To establish the reference value of C-reactive protein (CRP) among the Japanese population.
- To evaluate the predictive value of CRP measurement in hypercholesterolemic individuals.
- To assess the impact of statin therapy on cardiovascular events in patients with elevated CRP.
Summary:
- The upper limit of the reference value for CRP in Japanese individuals was determined to be 2.0 mg/l.
- Increased CRP levels are associated with a poorer prognosis for patients.
- Statin therapy demonstrated efficacy in the primary prevention of cardiovascular events in individuals with elevated CRP.
Impact:
- Provides crucial reference values for CRP in the Japanese population, aiding clinical interpretation.
- Highlights the prognostic significance of CRP levels in cardiovascular disease.
- Supports the use of statin therapy for primary cardiovascular event prevention in at-risk populations.